Lithium succinate

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Lithium succinate
Lithium succinate.png
Clinical data
AHFS/ Monograph
ATC code
PubChem CID
  • 10197702
  • 8373202 ☑Y
ECHA InfoCard 100.163.153
Chemical and physical data
Formula C4H5LiO4
Molar mass 124.02 g/mol g·mol−1
3D model (JSmol)
  • Interactive image

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis[1] and proposed for the treatment of anogenital warts.[2]


  1. ^ Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology. 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
  2. ^ Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International Journal of STD & AIDS. 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500.

Retrieved from ""
This content was retrieved from Wikipedia :
This page is based on the copyrighted Wikipedia article "Lithium succinate"; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA